Breast Cancer Survivor Provides Textured Wig Options to Women of Color 

In the midst of a lumpectomy, chemotherapy, and radiation for ​​breast cancer, Dianne Austin thought finding a wig to cover her balding head would be easy. She quickly learned otherwise.  As a Black woman, Austin desired a wig that resembled her tightly coiled, kinky and curly hair. This was 2015, and although several hospitals near … Read more

Dana-Farber Researchers Share Latest Blood Cancer and Blood Disorder Research

Dana-Farber physician-scientists presented results of more than 100 research studies at the 66th American Society of Hematology (ASH) annual meeting. Scientists shared findings across a range of hematologic disorders, underscoring the Institute’s dedication to innovation in hematologic oncology research, advances in early disease detection and intervention, and improving patient outcomes.   ASH is the world’s most comprehensive hematology … Read more

COVID-19 Vaccines for Cancer Patients and Survivors: Information to Know

Dana-Farber strongly encourages patients to get vaccinated for COVID-19 to protect themselves from serious infection of the virus. Family members, caregivers, and frequent household contacts also should also stay up to date with vaccinations to protect those around them.  COVID-19 vaccines have been given to millions of people and have proven safe and effective at … Read more

Are There Cancers of Red Blood Cells and Blood Platelets? 

While hematological cancers like leukemia, lymphoma, and multiple myeloma involve white blood cells, other, rarer hematologic malignancies affect red blood cells and platelets. These include polycythemia vera, in which the bone marrow produces too many red blood cells, and essential thrombocythemia, in which platelets levels are abnormally high. Both are chronic diseases that can usually … Read more

What is Protein Degradation? 

Protein degradation is a natural process by which cells break down proteins that are damaged or no longer needed so they can be recycled or disposed of.  Scientists at Dana-Farber and elsewhere are harnessing this process to destroy specific proteins involved in cancer, an approach known as targeted protein degradation. In contrast to traditional targeted … Read more

LGBTQ+ Patient Finds Care and Understanding at Dana-Farber 

As a longtime volunteer for the Red Cross, Jeanne Dodge knows the value of gaining as much information as possible about a situation or injured individual before administering aid. Making assumptions without all the facts can result in more harm than good in an emergency.  Accordingly, when Dodge comes to Dana-Farber for her multiple myeloma … Read more

Can Stem Cell Transplants Cure Cancer?

Stem cell transplantation refers to transplants of blood-forming stem cells taken from the bone marrow or collected from the bloodstream. Autologous transplants use the patient’s own stem cells, while allogeneic transplants use stem cells provided by a donor. Stem cell transplants offer some patients with blood-related cancers such as leukemia, lymphoma, and multiple myeloma the … Read more

A Family Navigates Challenges of Rare Blood Cancer Called Waldenström’s Macroglobulinemia

Tom Lomaglio, Jr., learned he had a rare blood cancer called Waldenström’s Macroglobulinemia (WM) in 2000. His father, Tom, Sr., had been diagnosed in 2004, and then his sister, Diane, in 2007. They were all referred to Dana-Farber for care. When Lomaglio visited the first time, he met Steven Treon, MD, PhD, director of the … Read more

Autologous or Allogeneic Stem Cell Transplants: Which Will My Doctor Recommend?

Both allogeneic and autologous stem cell transplants involve treating a patient with chemotherapy followed by an infusion of blood-forming stem cells, with a goal of curing the cancer or extending the time before the disease relapses. In adults, transplants are used to treat a range of blood-related cancers, myelodysplastic syndromes, and non-malignant blood disorders. Autologous … Read more

What are Natural Killer Cells and How Do They Fight Cancer?

Natural killer (NK) cells are white blood cells that serve as a part of the body’s first line of defense against infections and cancers. Along with T cells and B cells, NK cells have specialized roles as part of the immune system and have shown potential for being used in cancer immunotherapy. Their effectiveness is still being … Read more

FDA Approves New Treatment Option For Glioma

In an era when targeted therapies are often effective against multiple types of cancer, the U.S. Food and Drug Administration’s accelerated approval of a two-drug therapy for solid tumors carrying a specific mutation in the BRAF gene is a prime example of this trend. For patients with glioma brain cancer that harbors the mutation, the … Read more

Specially Equipped Natural Killer Cells Show Promise Against Form of AML

CAR T cells’ superpower is to identify cancer-related targets on the surface of tumor cells and order an attack on those cells. But they lack anything resembling X-ray vision to detect nefarious protein targets within tumor cells. That shortfall has limited their effectiveness in diseases like acute myelogenous leukemia (AML), in which tumor cells display few surface … Read more